vimarsana.com

Page 4 - Detection Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Is a blood test that screens for cancer worthwhile?

Biotech companies have a plan to try. That’s bad.

United statesDetection corpDrug administrationThrive earlier detection corpExact sciencesFive lawsHealth care

Exact Sciences Corp acquires Marshfield-based genetic testing lab for $190 million

Exact Sciences Corp. has acquired Marshfield-based genetic testing laboratory PreventionGenetics for $190 million.

United statesKevin conroyDetection corpSciences corpParadigm diagnostics incGenomic healthDrug administrationFashion analyticsViomics incExact sciencesExact science cologuardCalifornia based genomic healthParadigm diagnosticsBase genomicsMassachusetts based thrive earlier detectionPhoenix arizona

Exact Sciences announces third quarter 2021 results

/PRNewswire/ Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $456.4 million for the third quarter ended September.

San diegoUnited statesKatie boyceKevin conroyMegan jonesArmune biosciences incSciences on facebookTranslational genomics research institute tgenMedicare date of serviceGenomics incEpic sciencesUs preventive services taskNational comprehensive cancer networkAmerican cancer societyUnited states department of healthDetection corp

The Global Liquid Biopsy Market is Predicted to Reach US$ 9 53 Billion by 2028

/PRNewswire/ The "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type,.

South koreaUnited statesSouth koreanLaura woodClinical genomics technologies pty ltdExosome diagnostics incGuardant health incLucence diagnostics pte ltdCardiff oncology previously trovagene incDetection corpSciences corpRarecyte incBiocept incNeogenomics incOffice hours callFoundation medicine inc

The Global Liquid Biopsy Market is Predicted to Reach US$ 9 53 Billion by 2028

/PRNewswire/ The "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type,.

South koreaUnited statesSouth koreanLaura woodClinical genomics technologies pty ltdExosome diagnostics incGuardant health incLucence diagnostics pte ltdCardiff oncology previously trovagene incDetection corpSciences corpRarecyte incBiocept incNeogenomics incOffice hours callFoundation medicine inc

vimarsana © 2020. All Rights Reserved.